GREGORY D. PERRY

Insider Reports History

Location
Waltham, MA
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GREGORY D. PERRY:

Company Role Class Num Shares Value Price $ Report Date Ownership
Merus N.V. Chief Financial Officer & PFO Share Option (right to buy) 0 $1,450,696 $13.52 12 Dec 2025 Direct
KALA BIO, Inc. Director Common Stock 13,344 $53,909 $4.04 15 Jun 2025 Direct
Finch Therapeutics Group, Inc. Chief Financial Officer Employee Stock Option (right to buy) 80,000 25 Feb 2022 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 5,450 15 Jun 2025 Direct

Insider Reports Filed by GREGORY D. PERRY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRUS Merus N.V. 12 Dec 2025 11 $0 4 Chief Financial Officer & PFO 12 Dec 2025, 19:09
KALA KALA BIO, Inc. 15 Jun 2025 2 $0 4 Director 17 Jun 2025, 20:00
MRUS Merus N.V. 29 Jan 2025 1 $0 4 Chief Financial Officer & PFO 31 Jan 2025, 16:31
KALA KALA BIO, Inc. 11 Jun 2024 2 $0 4 Director 12 Jun 2024, 20:00
MRUS Merus N.V. 07 May 2024 1 $0 4 Chief Financial Officer & PFO 09 May 2024, 16:30
KALA Kala Pharmaceuticals, Inc. 22 Jun 2023 4 $0 4 Director 23 Jun 2023, 20:00
MRUS Merus N.V. 14 Jun 2023 1 $0 4 Chief Financial Officer 15 Jun 2023, 16:23
MRUS Merus N.V. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:14
KALA Kala Pharmaceuticals, Inc. 31 May 2023 4 $0 4 Director 02 Jun 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:45
MRUS Merus N.V. 31 May 2022 1 $0 4 Director 02 Jun 2022, 16:05
FNCH Finch Therapeutics Group, Inc. 25 Feb 2022 1 $0 4 Chief Financial Officer 28 Feb 2022, 17:50
KALA Kala Pharmaceuticals, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:30
MRUS Merus N.V. 28 May 2021 1 $0 4 Director 02 Jun 2021, 16:10